U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
WBP-220C
Preferred Name English
ENCELIMAB
INN  
Official Name English
Encelimab [WHO-DD]
Common Name English
encelimab [INN]
Common Name English
IMMUNOGLOBULIN G4 (222-PROLINE), ANTI-(HUMAN LYMPHOCYTE ACTIVATION GENE-3 PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL WBP220C .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL WBP220C .KAPPA.-CHAIN, DIMER
Common Name English
WBP220C
Code English
Code System Code Type Description
FDA UNII
N151VZIIPD
Created by admin on Tue Apr 01 21:55:36 GMT 2025 , Edited by admin on Tue Apr 01 21:55:36 GMT 2025
PRIMARY
SMS_ID
300000018843
Created by admin on Tue Apr 01 21:55:36 GMT 2025 , Edited by admin on Tue Apr 01 21:55:36 GMT 2025
PRIMARY
NCI_THESAURUS
C142978
Created by admin on Tue Apr 01 21:55:36 GMT 2025 , Edited by admin on Tue Apr 01 21:55:36 GMT 2025
PRIMARY
INN
11056
Created by admin on Tue Apr 01 21:55:36 GMT 2025 , Edited by admin on Tue Apr 01 21:55:36 GMT 2025
PRIMARY
CAS
2173096-82-5
Created by admin on Tue Apr 01 21:55:36 GMT 2025 , Edited by admin on Tue Apr 01 21:55:36 GMT 2025
PRIMARY
ACTIVE MOIETY
ENCELIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966